Press release content from World Newswire. The AP news staff members was not associated in its development.
Press release written content from Globe Newswire. The AP news employees was not included in its development.
SAN DIEGO, Feb. 04, 2021 (World NEWSWIRE) — Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical business devoted to the progress of progressive therapeutics for neurotology, now introduced it will report economic outcomes for the fourth quarter and whole calendar year 2020 and give a corporate update at 4:30 p.m. ET on February 11, 2021.
The are living phone may well be accessed by dialing (877) 305-6769 for domestic callers and (678) 562-4239 for intercontinental callers with convention ID code number: 3372182. A reside webcast of the connect with will be offered on the internet in the investor relations segment of Otonomy’s web site at www.otonomy.com and will be archived there for 30 times.
About Otonomy
Otonomy is a biopharmaceutical firm dedicated to the improvement of revolutionary therapeutics for neurotology. The company pioneered the application of drug delivery technology to the ear in get to create merchandise that reach sustained drug exposure from a solitary local administration. This strategy is coated by a wide patent estate and is being used to establish a pipeline of merchandise addressing significant unmet healthcare requires which includes Ménière’s sickness, hearing loss, and tinnitus. For further facts, be sure to take a look at www.otonomy.com.
Contacts:
Media Inquiries:
Spectrum Science
Chloé-Anne Ramsey
Vice President
404.865.3601
cramsey@spectrumscience.com
Trader Inquiries:
Westwicke ICR
Robert H. Uhl
Handling Director
858.356.5932
robert.uhl@westwicke.com